Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Cardiotoxicity 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma 3Sarcoma 2Leukemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1PRETEXT I Hepatoblastoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Lymphoma, Large B-Cell, Diffuse 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Inflammatory Breast Neoplasms 1Heart Failure 1Ganglioneuroblastoma 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 5Vincristine 4Prednisolone 3Methotrexate 3Doxorubicin 3Cytarabine 3pegfilgrastim 2Radiotherapy 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Early Intervention, Educational 2liposomal amphotericin B 1glutamic acid diethyl ester 1aldesleukin 1Vancomycin 1Valacyclovir 1Thioguanine 1Therapeutics 1Tazobactam 1Rituximab 1Ribavirin 1Psychiatric Rehabilitation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Palivizumab 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Dendritic Cell Sarcoma, Interdigitating × Dexrazoxane × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡